Try a single issue or save on a subscription Issues delivered straight to your door or device ...

Sleep apnea affects millions of people worldwide and prevents them from getting quality sleep. It negatively affects patients ...

(Another type, called central sleep apnea, occurs when the brain doesn ... “We hypothesized, and now have proven, that when you treat with tirzepatide, you remove some fat and the airway ...

The global sleep apnea implants market is expected to grow from USD 317.1 million in 2023 to USD 1,158.1 million by 2033, at ...

Awareness of sleep apnea and its relatively common and effective treatment has grown over the past three decades.

Though past research has focused on the health benefits of cheese, the new data examined its direct relationship to the ...

WAKE-UP CALL: 104m Indians or 11% of the population suffer from obstructive sleep apnea, according to a 2023 AIIMS study ...

Sleep apnea affects millions globally, often lurking undetected until it begins impacting overall health. While high blood ...

WASHINGTON - US regulators on Dec 20 approved the first drug treatment for sleep apnea, permitting the use of a weight-loss medication for the condition that affects millions of Americans.

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved ...

By Dani Blum The Food and Drug Administration on Friday approved the weight loss drug Zepbound to treat obstructive sleep apnea. It is the first prescription medication approved to treat the ...